αCD40 treatment induced marked changes in the tumour immune microenvironment, promoting the formation of an immune cell rich capsule separating the tumour from the normal pancreas, enhancing Th1 chemokine expression and cytotoxic T cell infiltration, and increasing PD-L1 expression. Here, CD274 is linked to neoplasm.